Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately:
●(See "Society guideline links: Crohn disease in adults".)
●(See "Society guideline links: Ulcerative colitis in adults".)
●(See "Society guideline links: Gastrointestinal bleeding in children".)
●(See "Society guideline links: Nutrition support (parenteral and enteral nutrition) in infants and children".)
Links to guidelines related to coronavirus disease 2019 (COVID-19) are also provided separately. (See "Society guideline links: COVID-19 – Index of guideline topics".)
International
●International Organization for the Study of Inflammatory Bowel Disease (IOIBD): Dietary guidance for the study of inflammatory bowel diseases (2020)
●World Gastroenterology Organisation (WGO): Global guidelines on inflammatory bowel disease, update (2015)
Canada
●Canadian Association of Gastroenterology (CAG): Clinical practice guideline for immunizations in patients with inflammatory bowel disease (IBD) – Part 1: Live vaccines (2021)
●CAG: Clinical practice guideline for immunizations in patients with inflammatory bowel disease (IBD) – Part 2: Inactivated vaccines (2021)
●Choosing Wisely Canada: Don't initiate or escalate long-term medical therapies for the treatment of inflammatory bowel disease (IBD) based only on symptoms (2021)
●Choosing Wisely Canada: Don't unnecessarily prolong the course of intravenous corticosteroids in patients with acute severe ulcerative colitis (UC) in the absence of clinical response (2021)
●Choosing Wisely Canada: Don't use abdominal computed tomography (CT) scan to assess inflammatory bowel disease (IBD) in the acute setting unless there is suspicion of a complication (obstruction, perforation, abscess) or a non-IBD etiology for abdominal symptoms (2021)
●Choosing Wisely Canada: Don't use opioids long-term to manage abdominal pain in inflammatory bowel disease (IBD) (2021)
●North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN): A position paper on anemia in children with inflammatory bowel disease (2020)
●NASPGHAN: Position paper on the evaluation and management for patients with very early-onset inflammatory bowel disease (2020)
●CAG: Clinical practice guideline for the medical management of pediatric luminal Crohn's disease (2019)
●CAG: Clinical practice guideline for the medical management of perianal fistulizing Crohn's disease – The Toronto consensus (2018)
●NASPGHAN: Clinical report on assuring quality for non-hospital-based biologic infusions in pediatric inflammatory bowel disease (2018)
●NASPGHAN: Clinical report on the role of combination therapy in pediatric inflammatory bowel disease (2018)
●NASPGHAN: A clinical report on hepatic issues and complications associated with inflammatory bowel disease (2017)
●NASPGHAN: Clinical report on postoperative recurrence in pediatric Crohn disease (2017)
●NASPGHAN: Clinical report on surveillance, diagnosis, and prevention of infectious diseases in pediatric patients with inflammatory bowel disease receiving tumor necrosis factor-alpha inhibitors (2016)
●CAG: Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease (2014)
●CAG: Position statement regarding the use of thiopurines for the treatment of inflammatory bowel disease (2014)
●NASPGHAN: Clinical report and consensus statement on the diagnosis and treatment of perianal Crohn disease (2013)
●NASPGHAN: Clinical report for self-management in pediatric inflammatory bowel disease (2013)
●NASPGHAN: Clinical report on psychosocial issues in pediatric inflammatory bowel disease (2013)
●NASPGHAN: Clinical report on the role of thiopurine metabolite testing and thiopurine methyltransferase determination in pediatric IBD (2013)
●NASPGHAN: Clinical guideline on use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease (2012)
●NASPGHAN: Recommendations for health supervision in the management of children and adolescents with IBD (2012)
●NASPGHAN: Clinical guideline on skeletal health of children and adolescents with inflammatory bowel disease (2011)
●CAG: Clinical practice guidelines on the use of tumour necrosis factor-alpha antagonist therapy in Crohn's disease (2009)
●NASPGHAN and Crohn's and Colitis Foundation of America (CCFA): Clinical report on differentiating ulcerative colitis from Crohn disease in children and young adults (2007)
United States
●American Gastroenterological Association (AGA): Clinical practice guideline on the role of biomarkers for the management of ulcerative colitis (2023)
●American College of Radiology (ACR): ACR Appropriateness Criteria on Crohn disease – Child (2021)
●American Society of Colon and Rectal Surgeons (ASCRS): Clinical practice guidelines for the surgical management of ulcerative colitis (2021)
●North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN): A position paper on anemia in children with inflammatory bowel disease (2020)
●NASPGHAN: Position paper on the evaluation and management for patients with very early-onset inflammatory bowel disease (2020)
●NASPGHAN: Clinical report on assuring quality for non-hospital-based biologic infusions in pediatric inflammatory bowel disease (2018)
●NASPGHAN: Clinical report on the role of combination therapy in pediatric inflammatory bowel disease (2018)
●American College of Gastroenterology (ACG): Clinical guideline on preventive care in inflammatory bowel disease (2017)
●NASPGHAN: A clinical report on hepatic issues and complications associated with inflammatory bowel disease (2017)
●NASPGHAN: Clinical report on postoperative recurrence in pediatric Crohn disease (2017)
●NASPGHAN: Clinical report on surveillance, diagnosis, and prevention of infectious diseases in pediatric patients with inflammatory bowel disease receiving tumor necrosis factor-alpha inhibitors (2016)
●American Society for Gastrointestinal Endoscopy (ASGE): Guideline on the role of endoscopy in inflammatory bowel disease (2015)
●NASPGHAN: Clinical report and consensus statement on the diagnosis and treatment of perianal Crohn disease (2013)
●NASPGHAN: Clinical report for self-management in pediatric inflammatory bowel disease (2013)
●NASPGHAN: Clinical report on psychosocial issues in pediatric inflammatory bowel disease (2013)
●NASPGHAN: Clinical report on the role of thiopurine metabolite testing and thiopurine methyltransferase determination in pediatric IBD (2013)
●NASPGHAN: Clinical guideline on use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease (2012)
●NASPGHAN: Recommendations for health supervision in the management of children and adolescents with IBD (2012)
●NASPGHAN: Clinical guideline on skeletal health of children and adolescents with inflammatory bowel disease (2011)
●NASPGHAN and Crohn's and Colitis Foundation of America (CCFA): Clinical report on differentiating ulcerative colitis from Crohn disease in children and young adults (2007)
Europe
●European Society for Clinical Nutrition and Metabolism (ESPEN): Guideline on clinical nutrition in inflammatory bowel disease (2023)
●European Crohn's and Colitis Organization (ECCO): Guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease (2021)
●European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN): A position paper on clinical genomics for the diagnosis of monogenic forms of inflammatory bowel disease (2021)
●ECCO-ESPGHAN: Guideline for the medical management of paediatric Crohn's disease, update (2020)
●ESPGHAN: Position statement on the use of biosimilars in pediatric inflammatory disease, update (2019)
●ECCO and ESPGHAN: An evidence-based guideline for the management of paediatric ulcerative colitis − Part 1: Ambulatory Care (2018)
●ECCO and ESPGHAN: An evidence-based consensus guideline for the management of paediatric ulcerative colitis − Part 2: Acute severe colitis (2018)
●ECCO-European Society of Gastrointestinal and Abdominal Radiology (ESGAR): Guideline for diagnostic assessment in IBD – Part 1: Initial diagnosis, monitoring of known IBD, detection of complications (2018)
●ECCO-ESGAR: Guideline for diagnostic assessment in IBD – Part 2: IBD scores and general principles and technical aspects (2018)
●ESPGHAN: Position paper on endoscopy in pediatric inflammatory bowel disease (2018)
●ESPGHAN: Position paper on nutrition in pediatric inflammatory bowel disease (2018)
●ESPGHAN: Guidelines for the surgical management of Crohn disease in children (2017)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Guideline on Crohn's disease – Management (2019)
●NICE: Guideline on ulcerative colitis – Management (2019)
●NICE: Quality standard on inflammatory bowel disease (2015)
●British Society of Gastroenterology (BSG): Reporting guidelines on inflammatory bowel disease biopsies, update (2013)
Australia–New Zealand
●Gastroenterological Society of Australia (GESA): Clinical update for general practitioners and physicians – Inflammatory bowel disease (2018)
Japan
●[In Japanese] Japan Gastroenterological Endoscopy Society (JGES): Guideline for endoscopic balloon dilatation for small bowel stricture in Crohn's disease (2021)
●[In Japanese] Japanese Society of Gastroenterology (JSGE): Evidence-based clinical practice guidelines for inflammatory bowel disease (IBD) (2020)
●[In English] Japanese Society for Pediatric Gastroenterology, Hepatology, and Nutrition (JSPGHAN): Guidelines for the treatment of Crohn's disease in children (2006)
●[In English] JSPGHAN: Guidelines for the treatment of ulcerative colitis in children (2004)
